{"id":4633,"date":"2014-12-12T17:25:17","date_gmt":"2014-12-12T17:25:17","guid":{"rendered":"http:\/\/www.scienceofdme.org\/?p=4633"},"modified":"2014-12-12T17:25:34","modified_gmt":"2014-12-12T17:25:34","slug":"anti-vegf-agent-aflibercept-approved-in-canada-for-treating-diabetic-macular-edema-dme","status":"publish","type":"post","link":"https:\/\/www.scienceofdme.org\/pt\/anti-vegf-agent-aflibercept-approved-in-canada-for-treating-diabetic-macular-edema-dme\/","title":{"rendered":"(English) Anti-VEGF Agent Aflibercept Approved in Canada for Treating Diabetic Macular Edema (DME)"},"content":{"rendered":"<p><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/posts\/4633"}],"collection":[{"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/comments?post=4633"}],"version-history":[{"count":2,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/posts\/4633\/revisions"}],"predecessor-version":[{"id":4635,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/posts\/4633\/revisions\/4635"}],"wp:attachment":[{"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/media?parent=4633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/categories?post=4633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/pt\/wp-json\/wp\/v2\/tags?post=4633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}